Emla and Cardio-respiratory arrest - a phase IV clinical study of FDA data

Summary:

Cardio-respiratory arrest is reported as a side effect among people who take Emla (lidocaine; prilocaine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lovenox, and have Nausea and vomiting.

The phase IV clinical study analyzes which people have Cardio-respiratory arrest when taking Emla. It is created by eHealthMe based on reports of 5,268 people who have side effects when taking Emla from the FDA, and is updated regularly.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.

What is Cardio-respiratory arrest?

Cardio-respiratory arrest (sudden dysfunction of heart and lungs) is found to be associated with 1,647 drugs and 1,767 conditions by eHealthMe. Check the latest studies of Cardio-respiratory arrest.

On Jul, 10, 2026

5,268 people reported to have side effects when taking Emla.
Among them, 39 people (0.74%) have Cardio-respiratory arrest.

Could Emla cause Cardio-respiratory arrest?

Among these 39 people:

How long have people been on Emla when they have Cardio-respiratory arrest? *

What is the gender of people who have Cardio-respiratory arrest when taking Emla? *

female: 84.21 %
male: 15.79 %

What is the age of people who have Cardio-respiratory arrest when taking Emla? *

What are other drugs people take besides Emla? *

What are other side effects people have besides Cardio-respiratory arrest? *

Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 7 people, 17.95%
Dyspnea (difficult or laboured breathing): 7 people, 17.95%
Nausea And Vomiting: 7 people, 17.95%
Unresponsive To Stimuli: 6 people, 15.38%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 15.38%
Hypotension (abnormally low blood pressure): 6 people, 15.38%
Respiratory Distress (difficulty in breathing): 5 people, 12.82%
Nausea (feeling of having an urge to vomit): 5 people, 12.82%
Atherosclerosis (disorder of the arteries): 4 people, 10.26%
Sedation: 4 people, 10.26%

What are the existing conditions these people have? *

Sepsis (a severe blood infection that can lead to organ failure and death): 10 people, 25.64%
Nausea And Vomiting: 10 people, 25.64%
General Anaesthesia: 9 people, 23.08%
Pain: 6 people, 15.38%
Spinal Muscular Atrophy (wasting of spinal muscles): 3 people, 7.69%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 7.69%
Eczema Infantile (allergic inflammation of the skin in young children): 2 people, 5.13%
Nausea (feeling of having an urge to vomit): 2 people, 5.13%
Diarrhea: 2 people, 5.13%
Depression: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Emla and have Cardio-respiratory arrest?

- Check whether Cardio-respiratory arrest is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emla:

Emla (5,276 reports)

Browse all side effects of Emla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardio-respiratory arrest:

Cardio-respiratory arrest (1,647 drugs)

Browse all the conditions that are associated with Cardio-respiratory arrest:

Cardio-respiratory arrest (1,767 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine; prilocaine (the active ingredients of Emla) and Emla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.